
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Noncoding RNAs in osteosarcoma: Implications for drug resistance
Zhengjun Lin, Xubin Xie, Shi Yao Lu, et al.
Cancer Letters (2021) Vol. 504, pp. 91-103
Closed Access | Times Cited: 27
Zhengjun Lin, Xubin Xie, Shi Yao Lu, et al.
Cancer Letters (2021) Vol. 504, pp. 91-103
Closed Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets
Jinxin Liu, Guanning Shang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 43
Jinxin Liu, Guanning Shang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 43
A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity
Ying Zhang, Zhaoyong Liu, Zhong Zhi-gang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11
Ying Zhang, Zhaoyong Liu, Zhong Zhi-gang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11
Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research
Longhao Chen, Liuji He, B. Liu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Longhao Chen, Liuji He, B. Liu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment
Amy Sarah Benjamin, Sunita Nayak
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
Amy Sarah Benjamin, Sunita Nayak
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma
Ting Chen, Jinxin Liu, He Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Ting Chen, Jinxin Liu, He Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2
Jinshan Tang, Gang Duan, Yunqing Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7351-7366
Open Access | Times Cited: 14
Jinshan Tang, Gang Duan, Yunqing Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7351-7366
Open Access | Times Cited: 14
Extracellular vesicles in tumorigenesis, metastasis, chemotherapy resistance and intercellular communication in osteosarcoma
Yi Liao, Qian Yi, Jinglong He, et al.
Bioengineered (2023) Vol. 14, Iss. 1, pp. 113-128
Open Access | Times Cited: 8
Yi Liao, Qian Yi, Jinglong He, et al.
Bioengineered (2023) Vol. 14, Iss. 1, pp. 113-128
Open Access | Times Cited: 8
CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis
Zuo-Wei Shi, Kaifu Wang, Yufei Xing, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Zuo-Wei Shi, Kaifu Wang, Yufei Xing, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Research Progress of Nanomaterials in Chemotherapy of Osteosarcoma
Tianci Yu, Zongyan Cai, Xingyu Chang, et al.
Orthopaedic Surgery (2023) Vol. 15, Iss. 9, pp. 2244-2259
Open Access | Times Cited: 7
Tianci Yu, Zongyan Cai, Xingyu Chang, et al.
Orthopaedic Surgery (2023) Vol. 15, Iss. 9, pp. 2244-2259
Open Access | Times Cited: 7
Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma
Chunlu Yan, Yinnan Dou, Ruoliu Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116924-116924
Open Access | Times Cited: 2
Chunlu Yan, Yinnan Dou, Ruoliu Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116924-116924
Open Access | Times Cited: 2
Blocking CXCR4 –CARM1 –YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis
Zihua Li, Hengli Lu, Yiwei Zhang, et al.
Cancer Science (2024) Vol. 115, Iss. 10, pp. 3305-3319
Open Access | Times Cited: 2
Zihua Li, Hengli Lu, Yiwei Zhang, et al.
Cancer Science (2024) Vol. 115, Iss. 10, pp. 3305-3319
Open Access | Times Cited: 2
Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
Yidan Xia, Dongxu Wang, Yuting Piao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Yidan Xia, Dongxu Wang, Yuting Piao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Radiomics analysis in differentiating osteosarcoma and chondrosarcoma based on T2-weighted imaging and contrast-enhanced T1-weighted imaging
Zhi Qin Gao, Zhongshang Dai, Zhengxiao Ouyang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Zhi Qin Gao, Zhongshang Dai, Zhengxiao Ouyang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
Tingrui Wu, Ziyu Ji, Hao Lin, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Tingrui Wu, Ziyu Ji, Hao Lin, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 7
EGR1 promoted anticancer effects of Scutellarin via regulating LINC00857/miR‐150‐5p/c‐Myc in osteosarcoma
Jian Han, Peng Wang, Xin Xia, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 17, pp. 8479-8489
Open Access | Times Cited: 8
Jian Han, Peng Wang, Xin Xia, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 17, pp. 8479-8489
Open Access | Times Cited: 8
Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma
Qingshan Huang, Cheng-long Chen, Jingbing Lou, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 4819-4827
Open Access | Times Cited: 8
Qingshan Huang, Cheng-long Chen, Jingbing Lou, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 4819-4827
Open Access | Times Cited: 8
Advancements in Understanding the Role of Circular RNA in Osteosarcoma
Jin Wang, Yan Zhang, Zi‐Cai Li
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2157-2167
Closed Access | Times Cited: 3
Jin Wang, Yan Zhang, Zi‐Cai Li
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2157-2167
Closed Access | Times Cited: 3
Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
Binxiang Chu, Haihong Zheng, Xiaohe Zheng, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
Binxiang Chu, Haihong Zheng, Xiaohe Zheng, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
Circular RNA-Related CeRNA Network and Prognostic Signature for Patients with Osteosarcoma
Gu Man, Ao Duan, Wanshun Liu, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 7527-7541
Open Access | Times Cited: 7
Gu Man, Ao Duan, Wanshun Liu, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 7527-7541
Open Access | Times Cited: 7
CircTNPO1 promotes the tumorigenesis of osteosarcoma by sequestering miR-578 to upregulate WNT5A expression
Yubo Shi, Yunyun Tian, Yanqing Wu, et al.
Cellular Signalling (2023) Vol. 111, pp. 110858-110858
Closed Access | Times Cited: 2
Yubo Shi, Yunyun Tian, Yanqing Wu, et al.
Cellular Signalling (2023) Vol. 111, pp. 110858-110858
Closed Access | Times Cited: 2
Preparation of polycation with hydroxyls for enhanced delivery of miRNA in osteosarcoma therapy
Dafu Chen, Bo-Wen Zhang, Jingjing Cao, et al.
Biomaterials Science (2022) Vol. 10, Iss. 11, pp. 2844-2856
Closed Access | Times Cited: 3
Dafu Chen, Bo-Wen Zhang, Jingjing Cao, et al.
Biomaterials Science (2022) Vol. 10, Iss. 11, pp. 2844-2856
Closed Access | Times Cited: 3
Decoding the Role of SLC25A5 in Osteosarcoma Drug Resistance and CD8+ T Cell Exhaustion: The Therapeutic Potential of Phyllanthin
Ning Tang, Woding Deng, Yupeng Wu, et al.
Phytomedicine (2024) Vol. 136, pp. 156291-156291
Closed Access
Ning Tang, Woding Deng, Yupeng Wu, et al.
Phytomedicine (2024) Vol. 136, pp. 156291-156291
Closed Access
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma
Chengran Wang, Yihong Zhang, Weihui Kong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8641-8660
Open Access
Chengran Wang, Yihong Zhang, Weihui Kong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8641-8660
Open Access
Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism
Zhicheng Li, Dan Wang, Xiaojun Zhu
Clinical & Translational Oncology (2024)
Closed Access
Zhicheng Li, Dan Wang, Xiaojun Zhu
Clinical & Translational Oncology (2024)
Closed Access
Disulfidoptosis‐related molecular subtypes and prognostic model for optimizing drug therapy in metastatic osteosarcoma patients
Xiaoping Wang, Chao Xie, Lijun Lin
The FASEB Journal (2024) Vol. 38, Iss. 24
Closed Access
Xiaoping Wang, Chao Xie, Lijun Lin
The FASEB Journal (2024) Vol. 38, Iss. 24
Closed Access